| Dopamine and drug addiction: the nucleus accumbens shell connection G Di Chiara, V Bassareo, S Fenu, MA De Luca, L Spina, C Cadoni, ... Neuropharmacology 47, 227-241, 2004 | 1105 | 2004 |
| Amphetamine, cocaine, phencyclidine and nomifensine increase extracellular dopamine concentrations preferentially in the nucleus accumbens of freely moving rats E Carboni, A Imperato, L Perezzani, G Di Chiara Neuroscience 28 (3), 653-661, 1989 | 727 | 1989 |
| Blockade of the noradrenaline carrier increases extracellular dopamine concentrations in the prefrontal cortex: evidence that dopamine is taken up in vivo by noradrenergic … E Carboni, GL Tanda, R Frau, GD Chiara Journal of neurochemistry 55 (3), 1067-1070, 1990 | 446 | 1990 |
| Increase of extracellular dopamine in the prefrontal cortex: a trait of drugs with antidepressant potential? G Tanda, E Carboni, R Frau, G Di Chiara Psychopharmacology 115, 285-288, 1994 | 384 | 1994 |
| Differential inhibitory effects of a 5-HT3 antagonist on drug-induced stimulation of dopamine release E Carboni, E Acquas, R Frau, G Di Chiara European journal of pharmacology 164 (3), 515-519, 1989 | 366 | 1989 |
| Drug addiction as a disorder of associative learning: role of nucleus accumbens shell/extended amygdala dopamine G DI CHIARA, G Tanda, V BASSAREO, F Pontieri, E Acquas, S FENU, ... Annals of the New York Academy of Sciences 877 (1), 461-485, 1999 | 318 | 1999 |
| SCH 23390 blocks drug-conditioned place-preference and place-aversion: anhedonia (lack of reward) or apathy (lack of motivation) after dopamine-receptor blockade? E Acquas, E Carboni, P Leone, G Di Chiara Psychopharmacology 99, 151-155, 1989 | 272 | 1989 |
| Cocaine and amphetamine increase extracellular dopamine in the nucleus accumbens of mice lacking the dopamine transporter gene E Carboni, C Spielewoy, C Vacca, M Nosten-Bertrand, B Giros, ... The Journal of Neuroscience 21 (9), RC141, 2001 | 240 | 2001 |
| 5HT3 receptor antagonists block morphine- and nicotine-but not amphetamine-induced reward E Carboni, E Acquas, P Leone, G Di Chiara Psychopharmacology 97, 175-178, 1989 | 224 | 1989 |
| PPAR‐gamma‐mediated neuroprotection in a chronic mouse model of Parkinson’s disease N Schintu, L Frau, M Ibba, P Caboni, A Garau, E Carboni, AR Carta European Journal of Neuroscience 29 (5), 954-963, 2009 | 222 | 2009 |
| Stimulation of in vivo dopamine transmission in the bed nucleus of stria terminalis by reinforcing drugs E Carboni, A Silvagni, MTP Rolando, G Di Chiara The Journal of neuroscience 20 (20), RC102, 2000 | 206 | 2000 |
| Serotonin release estimated by transcortical dialysis in freely-moving rats E Carboni, G Di Chiara Neuroscience 32 (3), 637-645, 1989 | 183 | 1989 |
| Profound depression of mesolimbic dopamine release after morphine withdrawal in dependent rats E Acquas, E Carboni, G Di Chiara Eur J Pharmacol 193 (1), 133-134, 1991 | 177 | 1991 |
| On the preferential release of dopamine in the nucleus accumbens by amphetamine: further evidence obtained by vertically implanted concentric dialysis probes G Di Chiara, G Tanda, R Frau, E Carboni Psychopharmacology 112, 398-402, 1993 | 154 | 1993 |
| Rosiglitazone decreases peroxisome proliferator receptor-gamma levels in microglia and inhibits TNF-alpha production: new evidences on neuroprotection in a progressive … AR Carta, L Frau, A Pisanu, J Wardas, S Spiga, E Carboni Neuroscience 194, 250-261, 2011 | 151 | 2011 |
| (D-Ala2) deltorphin II: D1-dependent stereotypies and stimulation of dopamine release in the nucleus accumbens R Longoni, L Spina, A Mulas, E Carboni, L Garau, P Melchiorri, ... Journal of Neuroscience 11 (6), 1565-1576, 1991 | 142 | 1991 |
| Estimation of in-vivo neurotransmitter release by brain microdialysis: the issue of validity. G Di Chiara, G Tanda, E Carboni Behavioural pharmacology 7 (7), 640-657, 1996 | 136 | 1996 |
| Dissociation of physical abstinence signs from changes in extracellular dopamine in the nucleus accumbens and in the prefrontal cortex of nicotine dependent rats E Carboni, L Bortone, C Giua, G Di Chiara Drug and alcohol dependence 58 (1-2), 93-102, 2000 | 122 | 2000 |
| 5-HT3 receptor antagonists block morphine-and nicotine-induced place-preference conditioning E Carboni, E Acquas, P Leone, L Perezzani, G Di Chiara European journal of pharmacology 151 (1), 159-160, 1988 | 110 | 1988 |
| Can pioglitazone be potentially useful therapeutically in treating patients with COVID-19? E Carboni, AR Carta, E Carboni Medical hypotheses 140, 109776, 2020 | 104 | 2020 |
